BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38446042)

  • 1. Development and Validation of a Deep Learning Model to Reduce the Interference of Rectal Artifacts in MRI-based Prostate Cancer Diagnosis.
    Hu L; Guo X; Zhou D; Wang Z; Dai L; Li L; Li Y; Zhang T; Long H; Yu C; Shi ZW; Han C; Lu C; Zhao J; Li Y; Zha Y; Liu Z
    Radiol Artif Intell; 2024 Mar; 6(2):e230362. PubMed ID: 38446042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated deep-learning system in the assessment of MRI-visible prostate cancer: comparison of advanced zoomed diffusion-weighted imaging and conventional technique.
    Hu L; Fu C; Song X; Grimm R; von Busch H; Benkert T; Kamen A; Lou B; Huisman H; Tong A; Penzkofer T; Choi MH; Shabunin I; Winkel D; Xing P; Szolar D; Coakley F; Shea S; Szurowska E; Guo JY; Li L; Li YH; Zhao JG
    Cancer Imaging; 2023 Jan; 23(1):6. PubMed ID: 36647150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
    Singh S; Rogers H; Kanber B; Clemente J; Pye H; Johnston EW; Parry T; Grey A; Dinneen E; Shaw G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Giganti F; Atkinson D; Moore CM; Whitaker HC; Alexander DC; Panagiotaki E; Punwani S
    Radiology; 2022 Dec; 305(3):623-630. PubMed ID: 35916679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of machine learning models based on biparametric MRI for diagnosis of prostate cancer and clinically significant prostate cancer].
    Qiao XM; Hu CH; Hu S; Hu CH; Wang XM; Shen JK; Ji LB; Song Y; Bao J
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1446-1454. PubMed ID: 37198106
    [No Abstract]   [Full Text] [Related]  

  • 5. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
    Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
    Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep-Learning Models for Detection and Localization of Visible Clinically Significant Prostate Cancer on Multi-Parametric MRI.
    Sun Z; Wu P; Cui Y; Liu X; Wang K; Gao G; Wang H; Zhang X; Wang X
    J Magn Reson Imaging; 2023 Oct; 58(4):1067-1081. PubMed ID: 36825823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a validated prostate MRI deep learning system to independent same-vendor multi-institutional data: demonstration of transferability.
    Netzer N; Eith C; Bethge O; Hielscher T; Schwab C; Stenzinger A; Gnirs R; Schlemmer HP; Maier-Hein KH; Schimmöller L; Bonekamp D
    Eur Radiol; 2023 Nov; 33(11):7463-7476. PubMed ID: 37507610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study.
    Zhao L; Bao J; Qiao X; Jin P; Ji Y; Li Z; Zhang J; Su Y; Ji L; Shen J; Zhang Y; Niu L; Xie W; Hu C; Shen H; Wang X; Liu J; Tian J
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):727-741. PubMed ID: 36409317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Evaluation of a Weakly Supervised Deep Learning Model for Lymph Node Diagnosis in Rectal Cancer at MRI.
    Xia W; Li D; He W; Pickhardt PJ; Jian J; Zhang R; Zhang J; Song R; Tong T; Yang X; Gao X; Cui Y
    Radiol Artif Intell; 2024 Mar; 6(2):e230152. PubMed ID: 38353633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.
    Hamm CA; Baumgärtner GL; Biessmann F; Beetz NL; Hartenstein A; Savic LJ; Froböse K; Dräger F; Schallenberg S; Rudolph M; Baur ADJ; Hamm B; Haas M; Hofbauer S; Cash H; Penzkofer T
    Radiology; 2023 May; 307(4):e222276. PubMed ID: 37039688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
    Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
    J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer.
    Montoya Perez I; Merisaari H; Jambor I; Ettala O; Taimen P; Knaapila J; Kekki H; Khan FL; Syrjälä E; Steiner A; Syvänen KT; Verho J; Seppänen M; Rannikko A; Riikonen J; Mirtti T; Lamminen T; Saunavaara J; Falagario U; Martini A; Pahikkala T; Pettersson K; Boström PJ; Aronen HJ
    J Magn Reson Imaging; 2022 Feb; 55(2):465-477. PubMed ID: 34227169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biparametric Magnetic Resonance Imaging-Derived Nomogram to Detect Clinically Significant Prostate Cancer by Targeted Biopsy for Index Lesion.
    Kim MJ; Park SY
    J Magn Reson Imaging; 2022 Apr; 55(4):1226-1233. PubMed ID: 34296803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators.
    Patel HD; Koehne EL; Shea SM; Fang AM; Gerena M; Gorbonos A; Quek ML; Flanigan RC; Goldberg A; Rais-Bahrami S; Gupta GN
    BJU Int; 2023 Feb; 131(2):227-235. PubMed ID: 35733400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Artificial Intelligence-Aided Diagnosis System for Clinically Significant Prostate Cancer with MRI: A Diagnostic Comparison Study.
    Jiang KW; Song Y; Hou Y; Zhi R; Zhang J; Bao ML; Li H; Yan X; Xi W; Zhang CX; Yao YF; Yang G; Zhang YD
    J Magn Reson Imaging; 2023 May; 57(5):1352-1364. PubMed ID: 36222324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
    Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
    J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning-Based Multiparametric MRI Model for Preoperative T-Stage in Rectal Cancer.
    Wei Y; Wang H; Chen Z; Zhu Y; Li Y; Lu B; Pan K; Wen C; Cao G; He Y; Zhou J; Pan Z; Wang M
    J Magn Reson Imaging; 2024 Mar; 59(3):1083-1092. PubMed ID: 37367938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.
    Bashkanov O; Rak M; Meyer A; Engelage L; Lumiani A; Muschter R; Hansen C
    Comput Methods Programs Biomed; 2023 Sep; 239():107624. PubMed ID: 37271051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study.
    Zhang J; Kang F; Gao J; Jiao J; Quan Z; Ma S; Li Y; Guo S; Li Z; Jing Y; Zhang K; Yang F; Han D; Wen W; Zhang J; Ren J; Wang J; Guo H; Qin W
    J Nucl Med; 2023 Nov; 64(11):1750-1757. PubMed ID: 37652543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
    Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.